DE19975044I2 - Verwendung von Adenosin zur Herstellung eines Arzneimittels f}r kontinuierliche Intraven¦se Infusionan menschlichen Patienten - Google Patents

Verwendung von Adenosin zur Herstellung eines Arzneimittels f}r kontinuierliche Intraven¦se Infusionan menschlichen Patienten

Info

Publication number
DE19975044I2
DE19975044I2 DE1999175044 DE19975044C DE19975044I2 DE 19975044 I2 DE19975044 I2 DE 19975044I2 DE 1999175044 DE1999175044 DE 1999175044 DE 19975044 C DE19975044 C DE 19975044C DE 19975044 I2 DE19975044 I2 DE 19975044I2
Authority
DE
Germany
Prior art keywords
adenosine
intravenous infusion
continuous intravenous
medicament
manufacture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE1999175044
Other languages
German (de)
English (en)
Inventor
Alf Sollevi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Item Development AB
Original Assignee
Item Development AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25116698&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE19975044(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Item Development AB filed Critical Item Development AB
Application granted granted Critical
Publication of DE19975044I2 publication Critical patent/DE19975044I2/de
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DE1999175044 1985-09-24 1985-10-29 Verwendung von Adenosin zur Herstellung eines Arzneimittels f}r kontinuierliche Intraven¦se Infusionan menschlichen Patienten Active DE19975044I2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US77951685A 1985-09-24 1985-09-24

Publications (1)

Publication Number Publication Date
DE19975044I2 true DE19975044I2 (de) 2006-02-02

Family

ID=25116698

Family Applications (4)

Application Number Title Priority Date Filing Date
DE1999175044 Active DE19975044I2 (de) 1985-09-24 1985-10-29 Verwendung von Adenosin zur Herstellung eines Arzneimittels f}r kontinuierliche Intraven¦se Infusionan menschlichen Patienten
DE19853590855 Withdrawn DE3590855T1 (https=) 1985-09-24 1985-10-29
DE3586993T Expired - Fee Related DE3586993T3 (de) 1985-09-24 1985-10-29 Kontinuierliche intravenöse infusion von adenosin an menschlichen patienten, einheitsdosierungsform von adenosin und dessen verwendung bei der herstellung von arzneimitteln.
DE3588205T Expired - Lifetime DE3588205T2 (de) 1985-09-24 1985-10-29 Verwendung von Adenosin zur Herstellung eines Arzneimittels für kontinuierliche Intravenöse Infusion an menschlichen Patienten

Family Applications After (3)

Application Number Title Priority Date Filing Date
DE19853590855 Withdrawn DE3590855T1 (https=) 1985-09-24 1985-10-29
DE3586993T Expired - Fee Related DE3586993T3 (de) 1985-09-24 1985-10-29 Kontinuierliche intravenöse infusion von adenosin an menschlichen patienten, einheitsdosierungsform von adenosin und dessen verwendung bei der herstellung von arzneimitteln.
DE3588205T Expired - Lifetime DE3588205T2 (de) 1985-09-24 1985-10-29 Verwendung von Adenosin zur Herstellung eines Arzneimittels für kontinuierliche Intravenöse Infusion an menschlichen Patienten

Country Status (9)

Country Link
EP (2) EP0275249B2 (https=)
JP (1) JP2535504B2 (https=)
AT (2) ATE176154T1 (https=)
AU (1) AU613304B2 (https=)
CA (1) CA1301652C (https=)
DE (4) DE19975044I2 (https=)
DK (1) DK253187D0 (https=)
NZ (1) NZ217592A (https=)
WO (1) WO1987001593A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2930589B2 (ja) * 1986-10-06 1999-08-03 ザ ユニバーシィティ オブ バージニア アルミニ パテンツ ファンデーション 外科手術中における改善された心臓保護のためのアデノシン，ヒポキサンチン及びリボース含有溶液の使用
US5070877A (en) * 1988-08-11 1991-12-10 Medco Research, Inc. Novel method of myocardial imaging
US5677290A (en) * 1990-05-10 1997-10-14 Fukunaga; Atsuo F. Therapeutic use of adenosine compounds as surgical anesthetics
US6004945A (en) * 1990-05-10 1999-12-21 Fukunaga; Atsuo F. Use of adenosine compounds to relieve pain
US5256398A (en) * 1990-11-08 1993-10-26 Whitby Research, Inc. Composition for determining viability of tissue
US5681278A (en) * 1994-06-23 1997-10-28 Cormedics Corp. Coronary vasculature treatment method
ES2909788T3 (es) 2010-10-15 2022-05-10 Seastar Medical Inc Cartucho de citaféresis y uso del mismo
JP5729660B2 (ja) * 2011-11-21 2015-06-03 株式会社ディナーヴ 腎動脈アブレーション用のカテーテルおよびシステム
EP2802367A4 (en) 2012-01-09 2015-12-16 H David Humes CARTRIDGE AND METHOD FOR INCREASING THE HEART MUSCULAR FUNCTION

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845205A (en) * 1970-06-04 1974-10-29 Univ Sydney 2-loweralkylthioadenosines
FR2129833B1 (https=) * 1971-03-16 1974-08-02 Cerm Cent Europ Rech Mauvernay
ZA7468B (en) * 1973-01-16 1974-11-27 J Voorhees Compositions and treatment of proliferatave skin diseases with phosphodiesterase inhibitors
DE3133925A1 (de) * 1981-08-27 1983-03-17 A. Nattermann & Cie GmbH, 5000 Köln Arzneimittel zur behandlung von hypertonie
DE3406533A1 (de) * 1984-02-23 1985-08-29 Boehringer Mannheim Gmbh, 6800 Mannheim Verwendung von adenosin-derivaten als antiallergica und arzneimittel, die diese enthalten

Also Published As

Publication number Publication date
WO1987001593A1 (en) 1987-03-26
DE3586993T3 (de) 1998-03-19
NZ217592A (en) 1990-10-26
JP2535504B2 (ja) 1996-09-18
DE3590855T1 (https=) 1988-08-25
ATE84419T1 (de) 1993-01-15
EP0506205B1 (en) 1999-01-27
DE3588205T2 (de) 1999-06-02
DE3586993D1 (de) 1993-02-25
ATE176154T1 (de) 1999-02-15
EP0506205A1 (en) 1992-09-30
DK253187A (da) 1987-05-19
EP0275249B1 (en) 1993-01-13
DE3586993T2 (de) 1993-04-29
DK253187D0 (da) 1987-05-19
AU5065585A (en) 1987-04-07
JPS63501497A (ja) 1988-06-09
AU613304B2 (en) 1991-08-01
EP0275249A1 (en) 1988-07-27
CA1301652C (en) 1992-05-26
EP0275249B2 (en) 1997-12-17
DE3588205D1 (de) 1999-03-11

Similar Documents

Publication Publication Date Title
DE60238142D1 (de) Implantierbares system
McDermott et al. The cardiovascular effects of low concentrations of nitrous oxide during morphine anesthesia
DE3662968D1 (en) Coronary perfusion pump
IT1154319B (it) Analizzatore di anidride carbonica nel flusso espiratorio finale per determinare la pressione parziale dell'anidride carbonica nel sangue arterioso di un paziente
NO167203C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive piperazinyl-derivater av puriner.
SE8506029L (sv) Hjert-lungsystem avsett for syresettning av en patients blod
GB2196854A (en) External pulsatile cardiac assist device
KR890001580A (ko) B형 간염 바이러스에 의해 유발되는 염증 질환을 치료하는 이중가닥 rna를 함유하는 약물
DE19975044I2 (de) Verwendung von Adenosin zur Herstellung eines Arzneimittels f}r kontinuierliche Intraven¦se Infusionan menschlichen Patienten
ZA874198B (en) D-fenfluramine for use in the treatment of depression
Neill et al. Acute and chronic cardiovascular adjustments to induced anemia in dogs
DK63488A (da) Anvendelse af human blod-koagulationsfaktor xiii til behandling af ulcerativ colitis
Thomas et al. Circulatory, psychological & performance variables during 100 hours of paced continuous exercise under conditions of controlled energy intake & work output.
Szatmary et al. Haemodynamic and antiischaemic protective effects of intra-aortic balloon counterpulsation in high risk coronary heart patients undergoing percutaneous transluminal coronary angioplasty
Davis et al. Comparison of changes in blood volume and opacity in dog digital pad and tongue.
Smith The coronary circulation
Lochner Present Basis of Coronary Therapy
HEWLETT The Action of Tyramin on the Circulation of Man
Slósarska et al. Physiological reactivity of patients with endogenous and neurotic depression.
MESHALKIN et al. Unsteady blood flow in humans under artificial conditions((Russian book))(Nestatsionarnyi krovotok u cheloveka v iskusstvennykh usloviiakh)
Jørstad et al. Intraarterial Blood Pressure Measurements During Electro Shock Convulsive Treatment with and Without a Muscle Relaxant (Succinylcholin Iodide)
Kudriashev et al. A model of regulation of several shifts in the circulatory system and prospects for its use in schizophrenic patients
Luchik Ophthalmodynamometric and Ophthalmoscopic Examinations in Patients with Transient Disorders of Cerebral Blood Circulation
SHULMAN et al. Hemodynamic effects of propiomazine
London Controversies in transfusion medicine: Directed blood donation, Page PL, Goldiner P, in: Transfusion, 29 (1989), pp. 65-74